GNI Ltd.

Shinjuku, Japan
Shinjuku, Japan
SEARCH FILTERS
Time filter
Source Type

News Article | May 4, 2017
Site: www.forbes.com

If the petroleum industry continues to fight subsidies for nuclear power, the nuclear industry will go after petroleum-industry tax breaks, the president of the Nuclear Energy Institute said Tuesday. "They might say, oh don’t subsidize this, but let me tell you, you open up the books and you might not call it a subsidy but I tell you there’s a lot of tax breaks that the American Petroleum Institute gets," said Maria Korsnick, president and CEO of NEI, the leading nuclear industry lobbying group. "If in fact that’s the playing field that we’re going to be set with, then you’re going to hear more about comparisons of subsidies vs. tax breaks in order to get all the information, if you will, out on the table." When people compare nuclear subsidies to petroleum tax breaks, Korsnick suggested, nuclear will fare well. "I would rather argue about the facts in terms of what value is being brought to the marketplace and what’s the value to the consumer as opposed to battling back and forth relative to this." The American Petroleum Institute, the largest lobbying group for oil and gas companies like ExxonMobile and Chevron, has lobbied against legislative efforts in several states to save aging nuclear plants that are struggling to compete against cheap natural gas and, in some places, cheap renewable energy. In Ohio, for example API Ohio Executive Director Chris Zeigler sent a message to state legislators: “Abundant natural gas has provided Ohio consumers with reliable and affordable energy and created countless jobs throughout the state without government subsidies,” Zeigler said. “Instead of subsidizing nuclear power companies, we should let the markets work to protect consumers." API accused the nuclear industry of misleading consumers about the consequences of closing nuclear plants, arguing that natural gas would continue to lower emissions even if two Ohio plants close. The nuclear industry has won support in New York and Illinois, with Exelon and Entergy benefitting. Lest those victories set a trend, the oil industry is raising objections in Ohio, Pennsylvania, and Connecticut. "Both of these were important in those states but they were also important to us in that they set a precedent," Korsnick said. "I think what you're seeing right now in the opposition is what happens when you’re successful—so we were successful in New York and we were successful in Illinois and I think now some folks are taking a look at that and saying wait a minute." Korsnick made the remarks at the end of a press conference in which nuclear interests argued again for their technology's relevance in the context of climate change, calling anew for policy changes to lower the cost, speed the deployment, and improve the oversight of new reactors. They released a report by the Global Nexus Initiative (GNI), a partnership between NEI and the Partnership for Global Security, a nuclear security think tank. "Based on our first two years of work, GNI has confirmed that it will be extremely difficult, if not impossible, to meet the goal of the Paris Agreement on climate change to limit temperature increases and decarbonize the global energy sector without a significant contribution from nuclear power," the report says. History of U.S. energy consumption by source[/caption] By Jeff McMahon, based in Chicago. Follow Jeff McMahon on Facebook, Google Plus, Twitter, or email him here.


The report "Liver Fibrosis - Pipeline Review, H1 2017" provides comprehensive information on the therapeutics under development for Liver Fibrosis (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Liver fibrosis is a scarring process which results in inflammation and liver cell death. Symptoms include abdominal pain, easy bruising, lack of appetite, nausea, tenderness and enlargement of the liver, weight loss and yellowing of skin and eyes. Risk factors include age, heavy alcohol consumption, and chronic infection with hepatitis B or C virus and weakened immune system. Liver Fibrosis (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Companies discussed in this report include  AdAlta Ltd, Advinus Therapeutics Ltd, Allergan Plc, Angion Biomedica Corp, Asubio Pharma Co Ltd, aTyr Pharma Inc, Beijing Kawin Technology Share-Holding Co Ltd, BioLineRx Ltd, Bioneer Corp, BiOrion Technologies BV, Bird Rock Bio Inc, Cellmid Ltd, ContraVir Pharmaceuticals Inc, Dicerna Pharmaceuticals Inc, Dr. Falk Pharma GmbH, Dynavax Technologies Corp, Evotec AG, Galectin Therapeutics Inc, Genfit SA, GenKyoTex SA, GNI Group Ltd, HanAll Biopharma Co Ltd, HEC Pharm Co Ltd, Immuron Ltd, Intercept Pharmaceuticals Inc, INVENT Pharmaceuticals Inc, Isarna Therapeutics GmbH, KineMed Inc, Nitto Denko Corp, Pfizer Inc, Pharmaxis Ltd, Promedior Inc, Promethera Biosciences SA, ProMetic Life Sciences Inc, Ribomic Inc, RXi Pharmaceuticals Corp, Samumed LLC, Silence Therapeutics Plc, Sirnaomics Inc, TaiwanJ Pharmaceuticals Co Ltd, TCM Biotech International Corp, TRACON Pharmaceuticals Inc, Vascular Biogenics Ltd, Virobay Inc plc, and XTuit Pharmaceuticals Inc. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=966744 . (This report is available at upto 25% Discount till June 02nd 2017.) "Liver Fibrosis Global Clinical Trials Review, H2, 2016" provides an overview of Liver Fibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Fibrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.


The report "Liver Fibrosis - Pipeline Review, H1 2017" provides comprehensive information on the therapeutics under development for Liver Fibrosis (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Liver fibrosis is a scarring process which results in inflammation and liver cell death. Symptoms include abdominal pain, easy bruising, lack of appetite, nausea, tenderness and enlargement of the liver, weight loss and yellowing of skin and eyes. Risk factors include age, heavy alcohol consumption, and chronic infection with hepatitis B or C virus and weakened immune system. Liver Fibrosis (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Companies discussed in this report include  AdAlta Ltd, Advinus Therapeutics Ltd, Allergan Plc, Angion Biomedica Corp, Asubio Pharma Co Ltd, aTyr Pharma Inc, Beijing Kawin Technology Share-Holding Co Ltd, BioLineRx Ltd, Bioneer Corp, BiOrion Technologies BV, Bird Rock Bio Inc, Cellmid Ltd, ContraVir Pharmaceuticals Inc, Dicerna Pharmaceuticals Inc, Dr. Falk Pharma GmbH, Dynavax Technologies Corp, Evotec AG, Galectin Therapeutics Inc, Genfit SA, GenKyoTex SA, GNI Group Ltd, HanAll Biopharma Co Ltd, HEC Pharm Co Ltd, Immuron Ltd, Intercept Pharmaceuticals Inc, INVENT Pharmaceuticals Inc, Isarna Therapeutics GmbH, KineMed Inc, Nitto Denko Corp, Pfizer Inc, Pharmaxis Ltd, Promedior Inc, Promethera Biosciences SA, ProMetic Life Sciences Inc, Ribomic Inc, RXi Pharmaceuticals Corp, Samumed LLC, Silence Therapeutics Plc, Sirnaomics Inc, TaiwanJ Pharmaceuticals Co Ltd, TCM Biotech International Corp, TRACON Pharmaceuticals Inc, Vascular Biogenics Ltd, Virobay Inc plc, and XTuit Pharmaceuticals Inc. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=966744 . (This report is available at upto 25% Discount till June 02nd 2017.) "Liver Fibrosis Global Clinical Trials Review, H2, 2016" provides an overview of Liver Fibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Fibrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.


Expanding two-wheeler and commercial vehicle fleet, lack of reliable public transportation system and increasing population to drive tire market in Thailand. New York, NY, May 03, 2017 --( Browse 10 market data Tables and 54 Figures spread through 123 Pages and an in-depth TOC on "Thailand Tire Market" https://www.techsciresearch.com/report/thailand-tire-market-forecast-and-opportunities/955.html In 2016, Bangkok region, which is the commercial and cultural hub of the country, held a majority share in the market, followed by north-eastern, northern, southern, eastern, western and central regions of the country. Bridgestone, a leading global tire player, dominated the country’s tire market in 2016, and the company is expected to lead the market during the forecast period as well. Thailand’s retreaded tire market is being driven by growing tire demand from truck and bus segments, as these tires cost comparatively less compared to the brand new tires. “Rising GNI per capita income as well as favorable government policies are estimated to further escalate growth of automotive industry in Thailand. The constantly surging automobile fleet size is driving demand for tires in the replacement segment. Thailand also exports a substantial percentage of domestically manufactured vehicles. With the growing demand for automobiles arising from the export markets, the country’s overall tire market is expected to grow rapidly over the period of next five years,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm. “Thailand Tire Market Forecast & Opportunities, 2022” has evaluated the future growth potential of Thailand tire market and provides statistics and information on market structure, size, share and future growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyzes emerging trends along with essential drivers, challenges and opportunities present in Thailand tire market. About TechSci Research TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends. Contact Mr. Ken Mathews 708 Third Avenue, Manhattan, NY, New York – 10017 Tel: +1-646-360-1656 Email: sales@techsciresearch.com New York, NY, May 03, 2017 --( PR.com )-- According to TechSci Research report, “Thailand Tire Market Forecast & Opportunities, 2022,” the market for tires in Thailand is projected to cross $5.6 billion mark by 2022, on account of expanding domestic demand, growing automobile fleet and favorable government policies. Few of the prime factors that impacted sale of light commercial vehicle and two-wheeler tires in the country were observed to be enhancing demand for LCV emanating from the logistics sector, and rising sales of two-wheelers due to growing requirement for convenient transportation in remote areas across the country. As per the World Bank, population of the country rose from 67.16 million in 2012 to 67.96 million in 2015. This continuing growth in population size has been observed to be the key reason for expanding fleet size of vehicles in Thailand. These multiple factors stated above are anticipated to drive the tire market in the country in the coming years.Browse 10 market data Tables and 54 Figures spread through 123 Pages and an in-depth TOC on "Thailand Tire Market"https://www.techsciresearch.com/report/thailand-tire-market-forecast-and-opportunities/955.htmlIn 2016, Bangkok region, which is the commercial and cultural hub of the country, held a majority share in the market, followed by north-eastern, northern, southern, eastern, western and central regions of the country. Bridgestone, a leading global tire player, dominated the country’s tire market in 2016, and the company is expected to lead the market during the forecast period as well. Thailand’s retreaded tire market is being driven by growing tire demand from truck and bus segments, as these tires cost comparatively less compared to the brand new tires.“Rising GNI per capita income as well as favorable government policies are estimated to further escalate growth of automotive industry in Thailand. The constantly surging automobile fleet size is driving demand for tires in the replacement segment. Thailand also exports a substantial percentage of domestically manufactured vehicles. With the growing demand for automobiles arising from the export markets, the country’s overall tire market is expected to grow rapidly over the period of next five years,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.“Thailand Tire Market Forecast & Opportunities, 2022” has evaluated the future growth potential of Thailand tire market and provides statistics and information on market structure, size, share and future growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyzes emerging trends along with essential drivers, challenges and opportunities present in Thailand tire market.About TechSci ResearchTechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.ContactMr. Ken Mathews708 Third Avenue,Manhattan, NY,New York – 10017Tel: +1-646-360-1656Email: sales@techsciresearch.com Click here to view the list of recent Press Releases from TechSci Research

Loading GNI Ltd. collaborators
Loading GNI Ltd. collaborators